Site
Innovation Forum began as a researcher-led Cambridge community before it became a company, an international branch network or an accelerator. This history brings together contemporary public records and a PharmaVentures interview with Dr Mira Kassouf, co-founder of Innovation Forum Oxford and its President in 2018.
Before Innovation Forum had accelerators, international branches or a formal legal identity, it had a simpler purpose: help researchers meet the people who could move scientific ideas towards practical use.
The surviving record shows that the Forum did not spring from one event or one incorporation document. It developed in stages. A Cambridge research community appeared in 2012. Conferences and venture competitions made its model visible from 2014. The present legal company followed in 2016, alongside a more structured accelerator programme.
A Cambridge Network profile records that Innovation Forum was established in 2012 by PhD students and postdoctoral researchers at the University of Cambridge. It places the launch in October and describes the original aim as connecting grassroots scientists with leaders in industry, investment and policy.
That early scope was deliberately broad. The organisation worked across life sciences, engineering, renewable energy, digital technology and nanotechnology. Healthcare would later become more prominent, but it should not be projected backwards as the Forum’s only founding concern.
In her later account, Mira describes the original idea as having been developed by Dr Marek Tyl with a group of friends who saw a missing platform in academic life. Early researchers needed closer contact with the people who could help turn knowledge into action. Her recollection captures the need the Forum was designed to meet, while the contemporary records establish the wider Cambridge setting.
An archived Cambridge University Students’ Union directory entry, last updated in July 2014, lists the organisation as Cambridge University Innovation Forum, or CUIF. It describes a multi-campus society active at Cambridge and London, building connections between academia, industry and government across disciplinary boundaries.
The entry is useful because it shows how the organisation presented itself close to its beginnings. It also distinguishes the historical university setting from the company that would be formed later.
The first independently documented flagship gathering was the Innovation Leaders Conference at Clare College on 27 and 28 February 2014. A University of Cambridge departmental publication advertised the two-day conference as bringing together 300 academics, business leaders, entrepreneurs and venture-capital participants. The programme combined keynote talks, workshops, research pitches and cross-sector discussion.
By 2015 the conference was being described as an annual event, while business-idea competitions were appearing in other university ecosystems. Convening and venture testing were becoming repeatable methods rather than a single Cambridge experiment.
The community existed for more than three years before its present legal vehicle. Companies House records show that Global Innovation Forum Limited, company number 10010132, was incorporated on 17 February 2016 as a company limited by guarantee without share capital.
This date is the company’s legal formation, not the beginning of the community. Keeping the two moments separate prevents a common historical mistake: treating incorporation as if it created all the activity that came before it.
The same year also brought a more structured route for science-led ventures. IMAGINE IF! was launched across local branches as a deep-technology competition and accelerator. Participants received workshops, mentoring and opportunities to pitch. The programme announced a global pool of 50 finalists, from which 15 teams were expected to pitch at the 2016 Leaders Conference, with US$30,000 in prizes advertised.
These are historical snapshots from contemporary publications. The branch, member and innovator totals were not published with consistent definitions or an underlying audited dataset, so they should not be combined into a growth curve or presented as current figures.
The Forum expanded by adapting a shared purpose to different university environments. Local volunteers could identify promising science, organise events and bring researchers into contact with investors, industry specialists, policymakers and public institutions. The central identity provided reach; the branches supplied local knowledge and trust.
This model was already visible in the archived 2014 Cambridge record, which referred to activity in Cambridge and London. By 2015, EPFL was describing Lausanne as the first Swiss branch. By 2017, the published network extended across 15 locations.
The model enabled rapid expansion without requiring a large conventional workforce, but it also depended heavily on volunteer continuity. Local leadership created energy and ownership; it could also make institutional memory fragile when organisers moved on.
The Oxford branch illustrates the next stage of the Forum’s development. In the 2017 PharmaVentures interview, Mira explains that the Oxford team entered an innovation ecosystem that was already crowded. Its task was not simply to add another conference. It had to understand the existing landscape, find where it could contribute and connect researchers with people who possessed complementary capabilities.
Her account also explains why the Forum’s grassroots identity mattered. Scientists were creating a platform for other scientists, speaking a familiar language while learning to understand the incentives of investors, industry, policymakers and healthcare organisations.
Mira later served as President of Innovation Forum Oxford in 2018. Her perspective belongs in this history because it records how the founding model was interpreted and applied by one of the branches: close to researchers, relatively independent and designed to create useful encounters between groups that did not naturally operate on the same terms.
The programmes, sectors and organisational structures changed, but the central problem remained recognisable. Researchers could generate important knowledge without having straightforward routes to the expertise, capital and institutions required to develop it.
Innovation Forum’s original response was to build those routes through community. Conferences created visibility. Competitions forced ideas into testable propositions. Mentors and investors supplied external challenge. Branches connected a common mission to local scientific ecosystems. IMAGINE IF! turned those practices into a more structured venture pathway.
The Forum’s history is therefore not simply the story of an events organisation or accelerator. It is the story of researchers building connective infrastructure around science: first in Cambridge, then through branches, programmes and partnerships in other innovation ecosystems.
Watch: PharmaVentures Insights: Innovation Forum Oxford, featuring Dr Mira Kassouf.
Source note: Historical audience and network figures are attributed to the contemporary publications linked above. They describe what those sources reported at the time and are not presented as independently audited or current statistics.